Phio Pharmaceuticals (PHIO) Invested Capital (2019 - 2021)

Phio Pharmaceuticals (PHIO) has reported Invested Capital for 3 consecutive years, with $21.9 million the latest figure, recorded in Q4 2021.

• For the quarter ending Q4 2021, Invested Capital rose 65.55% year-over-year to $21.9 million; the trailing twelve-month figure through Dec 2021 stood at $21.9 million (up 65.55% YoY), and the FY2021 full-year result was $21.9 million, up 65.55% from the prior year.
• Invested Capital retreated to $21.9 million in Q4 2021 per PHIO's latest filing, from $25.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $31.4 million in Q1 2021 and bottomed at $5.7 million in Q4 2019.
• Historically, Invested Capital has averaged $20.0 million across 3 years, with a median of $19.9 million in 2020.
• The sharpest annual moves came in 2020 and 2021: Invested Capital surged 130.48% in 2020, then soared 60.57% in 2021.
• Over 3 years, Invested Capital stood at $5.7 million in 2019, then surged by 130.48% to $13.2 million in 2020, then jumped by 65.55% to $21.9 million in 2021.
• According to Business Quant data, Invested Capital over the past three periods registered $21.9 million, $25.2 million, and $28.8 million for Q4 2021, Q3 2021, and Q2 2021 respectively.